Evidence map›Paper›PMID 25065683›Full record

ArticleThe American journal of pathology2014

Interferon-γ protects first-trimester decidual cells against aberrant matrix metalloproteinases 1, 3, and 9 expression in preeclampsia.

Charles J Lockwood, Murat Basar, Umit A Kayisli, Ozlem Guzeloglu-Kayisli, William Murk, Jenny Wang, Nicole De Paz, John P Shapiro, Rachel J Masch, Nihan Semerci and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. hCG: Biological Functions and Clinical Applications.International journal of molecular sciences · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Charles J LockwoodDepartment of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio. Electronic address: charles.lockwood@osumc.edu.
Murat BasarDepartment of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.
Umit A KayisliDepartment of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.
Ozlem Guzeloglu-KayisliDepartment of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.
William MurkDepartment of Chronic Disease Epidemiology, School of Public Health, Yale University, New Haven, Connecticut.
Jenny WangDepartment of Obstetrics and Gynecology, School of Medicine, Yale University, New Haven, Connecticut.
Nicole De PazDepartment of Obstetrics and Gynecology, School of Medicine, Yale University, New Haven, Connecticut.
John P ShapiroDepartment of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.
Rachel J MaschBeth Israel Medical Center, Albert Einstein College of Medicine, New York, New York.
Nihan SemerciDepartment of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.
S Joseph HuangDepartment of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.
Frederick SchatzDepartment of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.
The Ohio State University · USYale University · USAlbert Einstein College of Medicine · US

Funding

Progestin Effects on Uterine Hemostatis & AngiogenesisR01HD033937 · NICHD · YALE UNIVERSITY · PI LOCKWOOD, CHARLES JOSEPH · 1995 to 2011
$3.8M
The Role of Decidual Innate Immunity in the Pathogenesis of PreeclampsiaR01HD056123 · NICHD · YALE UNIVERSITY · PI HUANG, SE-TE JOSEPH · 2008 to 2012
$1.8M
NICHD NIH HHS 5R01HD056123NICHD NIH HHS R01 HD033937NICHD NIH HHS R01 HD056123
6 · The paper itself

Abstract

Human extravillous trophoblast (EVT) invades the decidua via integrin receptors and subsequently degrades extracellular matrix proteins. In preeclampsia (PE), shallow EVT invasion elicits incomplete spiral artery remodeling, causing reduced uteroplacental blood flow. Previous studies show that preeclamptic decidual cells, but not interstitial EVTs, display higher levels of extracellular matrix-degrading matrix metalloproteinase (MMP)-9, but not MMP-2. Herein, we extend our previous PE-related assessment of MMP-2 and MMP-9 to include MMP-1, which preferentially degrades fibrillar collagens, and MMP-3, which can initiate a local proteolytic cascade. In human first-trimester decidual cells incubated with estradiol, tumor necrosis factor-α (TNF-α) significantly enhanced MMP-1, MMP-3, and MMP-9 mRNA and protein levels and activity measured by real-time quantitative RT-PCR, ELISA, immunoblotting, and zymography, respectively. In contrast, interferon γ (IFN-γ) reversed these effects and medroxyprogesterone acetate elicited further reversal. Immunoblotting revealed that p38 mitogen-activated protein kinase signaling mediated TNF-α enhancement of MMP-1, MMP-3, and MMP-9, whereas IFN-γ inhibited p38 mitogen-activated protein kinase phosphorylation. Unlike highly regulated MMP-1, MMP-3, and MMP-9, MMP-2 mRNA and protein expression was constitutive in decidual cells. Because inflammation underlies PE-associated shallow EVT invasion, these results suggest that excess macrophage-derived TNF-α augments expression of MMP-1, MMP-3, and MMP-9 in decidual cells to interfere with normal stepwise EVT invasion of the decidua. In contrast, decidual natural killer cell-derived IFN-γ reverses such TNF-α-induced MMPs to protect against PE.

Indexed as

Blotting, WesternDeciduaEnzyme-Linked Immunosorbent AssayFemaleHumansImmunohistochemistryInterferon-gammaKiller Cells, NaturalMacrophagesMatrix Metalloproteinase 1Matrix Metalloproteinase 3Matrix Metalloproteinase 9Matrix Metalloproteinases, SecretedPre-EclampsiaPregnancyPregnancy Trimester, FirstInterferon-gammaMatrix Metalloproteinase 1Matrix Metalloproteinase 3Matrix Metalloproteinase 9Matrix Metalloproteinases, SecretedMMP1 protein, humanMMP3 protein, humanMMP9 protein, human

Identifiers

PMID25065683
PMCPMC4188280
OpenAlexW2144980322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.